<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
<channel xmlns:cfi="http://www.microsoft.com/schemas/rss/core/2005/internal" cfi:lastdownloaderror="None">
<title cf:type="text"><![CDATA[Editorial Board of Journal of Pharmaceutical Research -->COVID-19 Infection Column]]></title>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The quality management of clinical trials of antiviral drugs against SARS-CoV-2]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202307007&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Combined with the practice of clinical trial management, this article analyzed the quality management of clinical trials of antiviral drugs against SARS-CoV-2, described the organizational structure of quality assurance and the key points of quality control, summarized the quality problems of clinical trials of antiviral drugs against SARS-CoV-2, and proposed the improvement measures.]]></description>
<pubDate>2023/8/14 11:14:18</pubDate>
<category><![CDATA[COVID-19 Infection Column]]></category>
<author><![CDATA[JIANG Bo<sup>1,2</sup>, WANG Bailu<sup>1,2</sup>]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>JIANG Bo<sup>1,2</sup>, WANG Bailu<sup>1,2</sup></atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202307007&flag=1]]></guid><cfi:id>4</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Progress of research on preventing and treating COVID-19 with traditional Chinese medicine based on direct and indirect actions]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202307008&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Chinese medicine has played an important role in the prevention and treatment of COVID-19, not only by targeting multiple nodes of the viral life cycle, blocking viral invasion and replication, and playing a direct antiviral role, but also by regulating body homeostasis and playing an indirect regulatory role through enhancing body immunity, inhibiting cytokine storm and regulating intestinal flora. Therefore, based on systemic theory, this study organically integrates Chinese and Western medical thinking and combines clinical and experimental research progress to comprehensively explain the comprehensive mechanism of action of TCM in the prevention and treatment of neocon/neocon upper respiratory tract infections from a new perspective of direct regulation and indirect regulation.]]></description>
<pubDate>2023/8/14 11:14:18</pubDate>
<category><![CDATA[COVID-19 Infection Column]]></category>
<author><![CDATA[LIU Qiyu<sup>1</sup>, MU Hongyu<sup>2</sup>, GAO Yuan<sup>2</sup>, WANG Jiabo<sup>2</sup>]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>LIU Qiyu<sup>1</sup>, MU Hongyu<sup>2</sup>, GAO Yuan<sup>2</sup>, WANG Jiabo<sup>2</sup></atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202307008&flag=1]]></guid><cfi:id>3</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Multi-step virtual screening for searching the 3Clpro inhibitor of the main protease of the new coronavirus SRAS-CoV-2]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202310010&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>Objective</b>  To construct a multi-step virtual screening model and method to find an effective method for screening the 3Clpro inhibitor of the main protease of the new coronavirus SARS-CoV-2, so as to provide potential candidate drugs for COVID-19 drug research.<b>Methods</b>  Discovery Studio Client 2016 and Autodock vina 1.5.6 software were used to conduct structural-based virtual screening of 5811 compounds from the ZINC database, and the ligand-based pharmacophore model was constructed. After selecting the best model, the ligand-based virtual screening was performed. Finally, the antiviral drugs were screened based on pharmacological effects.<b>Results</b>  After three steps of screening, 11 compounds with high affinity, high fitting value and appropriate pharmacological effects were finally obtained.<b>Conclusion</b>  After three different screening, the candidate compounds with high activity can be quickly found, indicating that the virtual screening method and model are effective, which will greatly reduce the range of  drug screening against COVID-19 and provide potential research tools for future COVID-19 drug discovery.]]></description>
<pubDate>2023/11/13 15:04:29</pubDate>
<category><![CDATA[COVID-19 Infection Column]]></category>
<author><![CDATA[DU Hongjin<sup>1</sup>, YU Xiaotan<sup>2,3</sup>, LI Hanxu<sup>2</sup>, WAN Luoting<sup>2</sup>, ZOU Yu<sup>2</sup>]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>DU Hongjin<sup>1</sup>, YU Xiaotan<sup>2,3</sup>, LI Hanxu<sup>2</sup>, WAN Luoting<sup>2</sup>, ZOU Yu<sup>2</sup></atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202310010&flag=1]]></guid><cfi:id>2</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Practice and exploration of pharmacy in Shanghai Longyao Road mobile cabin hospital]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202310011&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>Objective</b>  To explore the pharmaceutical management and pharmaceutical practice of Longyao Road mobile cabin hospital in Shanghai under the epidemic situation.<b>Methods</b>  Establishing a pharmaceutical emergency working group to complete the transformation of the shelter pharmacy, the construction of the personnel management system and the pharmacy system; Straightening out the work flow of the shelter pharmacy, exploring the prevention and control of nosocomial infection in the pharmacy and the mode of safe medication outside the cabin; Establishing a "zero contact" pharmaceutical care mode in the shelter pharmacy.<b>Results</b>  Pharmaceutical care was provided to 2369 patients. In addition to ensuring the safe and timely supply of drugs, it also provided patients with medication consultation, pharmaceutical science popularization and humanistic care, which were unanimously praised by patients. In the 36 day work, it achieved the effect of "zero error" in deployment, zero infection of staff and great satisfaction of patients.<b>Conclusion</b>  The pharmaceutical care mode of Longyao road shelter hospital provides a strong guarantee for the hospital to complete its tasks successfully, and provides experience for the construction of shelter pharmacies in the future, especially those with relatively simple conditions.]]></description>
<pubDate>2023/11/13 15:04:29</pubDate>
<category><![CDATA[COVID-19 Infection Column]]></category>
<author><![CDATA[WU Yubao, QI Benbin, ZHANG Xiaoli, SONG Chao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>WU Yubao, QI Benbin, ZHANG Xiaoli, SONG Chao</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202310011&flag=1]]></guid><cfi:id>1</cfi:id><cfi:read>true</cfi:read></item>
</channel>
</rss>